BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2012
View Archived Issues
Polymorphism improves recovery after HBV infection
Read More
Studies show utility of florbenazine F18 in Parkinson's disease settings
Read More
Researchers at Piramal Life Sciences prepare new PI3Kalpha inhibitors
Read More
Siena Biotech patents new SMO receptor antagonists
Read More
Novel FPR2/ALX receptor agonists divulged by Actelion Pharmaceuticals
Read More
New myostatin-targeted antibody shows promise to treat cancer
Read More
New candidate cancer therapeutics designed at CSIR
Read More
Novel recombinant protein product prevents muscle damage in muscular dystrophy model
Read More
Boehringer Ingelheim presents novel MPGES-1 inhibitors
Read More
Phase I trial assesses ASG-5ME in castration-resistant prostate cancer
Read More
Astellas plans Japanese launch of extended-release tablet for restless legs syndrome
Read More
First EMA-approved artemisinin-based combination drug for uncomplicated malaria is available
Read More
Application filed in U.S. for Kineret in new indication
Read More
Endpoints met in pivotal trial of Vifor phosphate binder
Read More
Bayer product enters phase II/III hemophilia A study
Read More
New trial testing anti-inflammatory properties of RPL-554
Read More
BrainStorm Cell Therapeutics discloses encouraging data on ALS therapy
Read More
Tuberculosis partnership launches first screening round for new drug candidates
Read More
FDA approves first KRAS companion diagnostic test and Erbitux for new indication
Read More
Investigators identify possible new therapeutic target for osteoarthritis
Read More
Medigene grants exclusive EndoTAG-1 rights to SynCore
Read More
Epistem obtains CE-IVD registration for TB test
Read More
Uriach and Hyphens Pharma extend collaboration
Read More
